Skip to content

Evaluation of the Impact of an Acupuncture Session in Healthy Volunteers on the Kinetics of Cerebral Activity Using the Bispectral Index (BIS)

Randomized Propective Study Evaluating the Impact of an Acupuncture Session in Healthy Volunteers on the Kinetics of Cerebral Activity Using the Bispectral Index (BIS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05108961
Acronym
Bisprectral2
Enrollment
30
Registered
2021-11-05
Start date
2022-04-19
Completion date
2023-01-13
Last updated
2023-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture, Healthy Volunteers

Brief summary

To be able to have data on brain activity during an acupuncture session, this pilot study is necessary to evaluate the kinetics of the bispectral index. This research aims to evaluate the kinetics of the bispectral index in healthy volunteers during an acupuncture session, Sham acupuncture or resting in a lying position.

Interventions

PROCEDUREAcupuncture

one session with precise acupunture points

BEHAVIORALA digital stress scale

The digital stress scale before and after the session: Oral digital scale. The doctor asks the participant to quantify their anxiety on a virtual scale ranging from 0 (absent anxiety) to 10 (maximum anxiety imaginable)

BEHAVIORALa relaxation questionnaire

The Global Relaxation Questionnaire after the session: Dovero Global Relaxation Scale

DIAGNOSTIC_TESTBispectral Index

BIS is based on an EEG analysis algorithm

Sponsors

European Clinical Trial Experts Network
CollaboratorOTHER
Clinique saint martin Pessac
CollaboratorUNKNOWN
Elsan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteer * Over 18 years old and less than 65. * Having given his express consent * Affiliated to a social security scheme or beneficiary of such a scheme

Exclusion criteria

* Medical history of psychiatric disorders * Psychotropic treatment * narcolepsy * Obstructive sleep apnea syndrome * Symptoms that may correspond to COVID 19 * Nickel allergy * Refusal to participate in the study * Protected subjects : Adults under guardianship, curatorship or other legal protection deprived of their liberty by judicial or administrative decision * Pregnant, breastfeeding or parturient woman * Subject hospitalized without consent

Design outcomes

Primary

MeasureTime frameDescription
Bispectral Index35 minutesBispectral Index (BIS) measured every second for 35 min through an EEG

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026